Alexandre de la Taille
MD, PHD.
Current positions
- Head of the Urology Department of the CHU Mondor, Assistance Publique des Hôpitaux de Paris, Créteil, France (since 2012)
- President of the French Association of Urology (2022-2025)
- Vice President of the Departmental Council of the Order of Physicians (2021-2024)
- Associate Editor of the World Journal of Urology
- President of the Association for Research on Prostate Diseases (www.iartp.org)
- Member of the TReCAP prostate cancer research team (EU-UPEC)
Diplomas
- Doctorate in Medicine in September 2000
- PHD December 2000
- Research Grant (Columbia University, New York-USA, November 1997 – October 1999)
- Certificates in Laparoscopy, Andrology, Statistics, Abdo-Pelvic Anatomy, Urodynamics
- ICH GCP Training 28/2/20
Price
- Matula Crystal Award – European Association of Urology 2006
- EAU Thesis Award 2001 – Sanofi-synthelabo – “Biomarkers of apoptosis in prostate cancer.”
- First Prize in the 1999 AAU/Circon-ACMI Trial Competition “Cadherin T6, a novel cadherin family protein involved in the acquisition of therapeutic resistance in prostate cancer cells.”
Teaching
- Responsible for teaching robotic surgery at Henri Mondor University Hospital
- Teaching robotic surgery with the Da Vinci system: kidney and prostate surgery in collaboration with Intuitive Surgical
- Organizer of congresses and symposiums in the field of robotic surgery and uro-oncology: UROP, UDOU, UCARE
- Teacher at IRCAD: surgical demonstrations by videoconference
- Collaboration with St. Jospeh Hospital and USEK (Lebanon), training of residents
Search
Professor Alexandre de la Taille started his research on circulating cells in prostate cancer in Professor Chopin’s team and then at Columbia University with Professor Buttyan on markers of apoptosis in prostate cancer. He continued in France by taking the direction of the INSERMU977Eq07 team on biomarkers in prostate cancer. He is currently involved in the research on exosomes in prostate cancer within the TReCAP team of Pr Vacherot.
Organization of congresses
- Updates in Onco-Urology
- UROP Prostate 2022
- Association for Prostate Tumor Research
Publications
More than 540 original articles have been published on basic research work but also on the development of laparoscopic and robotic surgery. List of publications in MedLine; click here
Professor Alexandre de la Taille has participated in the writing of more than 12 book chapters and has been invited as a speaker or presented his work in the congresses of AFU, EAU, AUA, SLU (Lebanon), SIU, China, Tunisia, Morocco, Algeria, Italy, Switzerland, Syrian, Colombian, Argentina, Australia, Japan, United Arab Emirates, Turkey, Egypt, Romania, Portugal, England and the United States.
Didactic books
Prostate: we tell you everything
Functioning, ailments, health, sexuality, prevention.
Urology: Passing the ECNi
In perfect coherence with the DFASM program and the ECNi, this book brings together the fundamental knowledge in urology.
List of the last 20 articles as 1st author
- Let's ride against prostate cancer!
- Attention, l’urologie et la médecine évoluent (enfin ?)…
- Alpha-blockers or hexanic extract of Serenoa repens for 6 months: sub-analysis of the PERSAT study
- Nerve-sparing Techniques During Robot-assisted Radical Prostatectomy: Clips or Low-energy Bipolar Coagulation? Low Energy
- Alpha-blockers or phytotherapy as first-line treatment of LUTS/BPH in general medicine: The PERSAT non-interventional study
- Consequences of prostatic obstruction on bladder function, impact of removal, and management of recurrence after surgery
- How to prevent LUTS due to BPH development and progression
- Psychological impact of prostate cancer on patients receiving a 6-month androgen deprivation therapy
- Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy
- Sometimes a Simple Old-Fashioned and Low Cost Pathological Parameter Can be Useful
- Comment on "secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot study"
- Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions
- Observational study CAPITAL and prescription of hormonotherapy by French urologists in daily practice
- Circumstances of prescription of hormone therapy for patients with prostate cancer
- Contribution of the PCPT trial to finasteride treatment of micturition disorders due to benign prostatic hyperplasia
- Open to debate. The motion: at least 18 cores are necessary to make a prostatic biopsy useful
- Progensa PCA3 test for prostate cancer detection
- Over the past decade, prostate needle biopsies have been studied widely
- Value of antidiuretic, anticholinergic, and anti-inflammatory drugs and botulinum toxin for the treatment of voiding disorders related to BPH (CTMH-AFU forum 2005)
- The role of the IPSS (International Prostate Symptoms Score) to evaluate the frequency of disability induced by each of the 7 symptoms. (CTMH-AFU study)
List of the last 20 articles of the team
- Differences in the product characteristics and clinical use of granulocytes for transfusion: The BEST Collaborative study May 15, 2025
- Artificial intelligence for enhanced classification of intraoperative complications in urology May 12, 2025
- Eliciting the Impact of Metformin and Statins on Prostate Cancer Outcomes from a Real-life National Database Analysis May 10, 2025
- External validation of current quality care metrics after radical nephroureterectomy April 21, 2025
- Relationship Between Radiation Therapy and Fecal Incontinence in Patients Treated for Localized Prostate Cancer: Results of the French ICONES Study January 15, 2025
- Microemulsion-Inspired Polysaccharide Nanoparticles for an Advanced Targeted Thrombolytic Treatment January 8, 2025
- Environmental impact of current endoscopic technology in urological procedures: a systematic review on reusable vs. disposable scopes December 5, 2024
- Anatomic Factors Associated with Complications After Radical Prostatectomy: A Systematic Review and Meta-analysis November 19, 2024
- International Forum on Donor- and Recipient-triggered Lookback for Traditional Transfusion-transmitted Infections: Responses November 14, 2024
- International Forum on Donor- and Recipient-triggered Lookback for Traditional Transfusion-transmitted Infections: Summary November 14, 2024
- Letter to the editor for the article "Pilot study for bladder cancer detection with volatile organic compounds using ion mobility spectrometry: a novel urine-based approach" September 20, 2024
- Impact of robotic-assisted surgery on length of hospital stay in Paris public hospitals: a retrospective analysis September 4, 2024
- Contribution of canine olfaction in the diagnostic strategy of intermediate and high-risk prostate cancer: a double-blind validation study August 25, 2024
- Open versus robotic partial nephrectomy in obese patients: a multi-institutional propensity score-matched analysis (UroCCR 43-Robese study) April 6, 2024
- Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer March 27, 2024
- A Comprehensive National Survey of Prostate-specific Antigen Testing and Prostate Cancer Management in France: Uncovering Regional and Temporal Disparities March 12, 2024
- Urologists and Sustainability: The First Survey from the French Sustainability Working Group February 23, 2024
- Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review January 20, 2024
- REVIEW: "ISCHEMIC STROKE: From Fibrinolysis to Functional Recovery" Nanomedicine: emerging approaches to treat ischemic stroke December 6, 2023
- BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model November 25, 2023